Technical Specifications Compound: BPC-157 (Synthetic Pentadecapeptide) Format: Lyophilized peptide powder Strength: 10 mg per vial Purity: 9899% (COA included) Appearance: White lyophilized powder Category: Research peptide reagent Intended Use This product is intended strictly for: Laboratory experimentation In-vitro scientific research Biochemical and molecular studies Non-human preclinical model development Institutional or academic research programs Not intended for: Human or animal consumption Injection, ingestion, inhalation, or topical use Medical, therapeutic, diagnostic, or cosmetic purposes This compound is not approved by Health Canada, FDA, or any regulatory authority for clinical use
Supports a healthy lean mass (muscle) to fat mass ratio
IGF-1 LR3 is a modified peptide research compound studied in laboratory settings for its relevance to insulin like growth factor signalling, receptor interaction, and extended activity profile investigation
Therapeutic Use Exemption Program It should be noted that for athletes who have a legitimate medical reason for using a prohibited substance or method that is on the List, they can apply for a Therapeutic Use Exemption (TUE) to determine whether they meet the criteria outlined in the International Standard for Therapeutic Use Exemptions (ISTUE)
Percent of Survey Respondents Taking the Peptides Being Reviewed BPC-157: 18% TB-500: 16% Wolverine Stack (BPC-157 + TB-500): 18% Emideltide / DSIP: 16.7% Semax: 16% Epitalon: 14% KPV: 11.5% MOTS-c: 9% The peptides under review are often sold online with labels such as for research use only, meaning they are intended for laboratory research rather than human use
